HuagongsheHuagongshe Chemistry Print Report · For research reference only
2-(Trifluoromethoxy)benzyl bromide → 4-{5-[4-Methoxymethyl-4-(2-trifluoromethoxybenzyl)-piperidine-1-ylmethyl]-2-methylimidazol-1-ylmethyl}benzonitrile hydrochloride salt
Participants
| Role | Name | HCID | Charge |
|---|---|---|---|
| Reactant | 2-(Trifluoromethoxy)benzyl bromide | HCID 2777254 | — |
| Reactant | 1-(4-Cyanobenzyl)-5-chloromethyl-2-methylimidazole hydrochloride salt | HCID 21193348 | — |
| Reactant | N-tert-butoxy-carbonyl-4-(2-trifluoromethoxybenzyl)-4-hydroxymethylpiperidine | HCID 86754054 | — |
| Product | 4-{5-[4-Methoxymethyl-4-(2-trifluoromethoxybenzyl)-piperidine-1-ylmethyl]-2-methylimidazol-1-ylmethyl}benzonitrile hydrochloride salt | HCID 21193166 | — |
Reaction Steps
The title compound was prepared using the protocol described in Example 30, Step A-C using 2-(trifluoromethoxy)benzyl bromide in Step B, and in Example 52, Step B-E substituting N-tert-butoxycarbonyl-4-(3-methylbenzyl)-4-hydroxymethylpiperidine with N-tert-butoxy-carbonyl-4-(2-trifluoromethoxybenzyl)-4-hydroxymethylpiperidine in Step B, and substituting 1-(4-cyanobenzyl)-5-chloromethyl-imidazole hydro-chloride salt with 1-(4-cyanobenzyl)-5-chloromethyl-2-methylimidazole hydrochloride salt in Step E.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patent number | US06248756B1 |
| Source dataset | uspto-grants-2001_06 |
| ORD ID | ord-5a8017630dcb482dac663225672f30c0 |
| Source note | uspto-grants-2001_06 |